Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Adlyxin to treat type 2 diabetes

July 28, 2016Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes.

Post navigation

← Let’s Do Lunch, Inc., dba Integrated Food Service, Expands Voluntary Recall Statement from Peter Marks, M.D., Ph.D., Director, FDA’s Center for Biologics Evaluation and Research →
Proudly powered by WordPress